Motretinide
Appearance
This article needs additional citations for verification. (November 2023) |
![]() | |
Names | |
---|---|
IUPAC name
N-Ethyl-3-methoxy-2-methyl-1,2,3,4-tetradehydro-17-norretinamide
| |
Systematic IUPAC name
(2E,4E,6E,8E)-N-Ethyl-8-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenamide | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.054.613 |
EC Number |
|
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C23H31NO2 | |
Molar mass | 353.49774 |
Pharmacology | |
D10AD05 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Motretinide is an anti-acne preparation and aromatic analog of retinoic acid.[1]
References
[edit]- ^ Zouboulis, C. C. (2001). "Retinoids--which dermatological indications will benefit in the near future?". Skin Pharmacology and Applied Skin Physiology. 14 (5): 303–315. doi:10.1159/000056361. PMID 11586072.